Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Axonics (NASDAQ:AXNX) quickly edged higher by 0.8% after a Nasdaq delisting notice for its planned sale to Boston Scientific ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Boston Scientific Corporation (NYSE:BSX)宣布恢复其AVANT GUARD临床试验,该试验针对一组新的持续性心房颤动未经药物治疗的患者。此前该试验因需要评估观察结果而暂停,但经过仔细审查并与研究数据监测委员会协商后,试验招募将继续进行。 AVANT GUARD试验是Boston Scientific的一项重要研究,该公司以开发和生产用于介入医学专科的医疗器械而 ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Boston Scientific ( NYSE: BSX) has agreed to acquire privately held medical technology company, Cortex, Inc.

Robust revenue growth and solid market positioning underscore Boston Scientific's strengths. Operational challenges and competitive pressures highlight potential areas for improvement. Emerging ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company. Cortex is a ...

马萨诸塞州马尔伯勒 - Boston Scientific Corporation (NYSE: BSX) 今天公布了其ACURATE IDE临床试验的主要终点结果。该试验评估了ACURATE neo2™主动脉瓣系统在各种手术风险类别的严重主动脉狭窄患者中的表现。这些发现在2024年Transcatheter Cardiovascular Therapeutics® (TCT®)研讨会上公布。 该 ...

The shares of this wide-moat company look compelling today. We sell different types of products and services to both investment professionals and individual investors. These products and services ...